TOPICS

Category: Rosacea

Topical Oxymetazoline Hydrochloride Cream 1% for the Treatment of Persistent Facial Erythema of Rosacea in Adults: A Comprehensive Review of Current Evidence

J Clin Aesthet Dermatol. 2021;14(3):32–37. by James Q. Del Rosso, DO, and Emil Tanghetti, MD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada, is with Thomas Dermatology in Las Vegas, Nevada, and is an adjunct clinical professor of dermatology at Touro University Nevada in Henderson, Nevada. Dr. Tanghetti is

CONTINUE READING »

Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea

J Clin Aesthet Dermatol. 2021;14(3):42–45. by Andres Luque, MD; AIDA PAOLA ROJAS, MD; Andrea Ortiz-Florez, MD; and Juliana Perez-Bernal, MD All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to the content of this

CONTINUE READING »

Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions

J Clin Aesthet Dermatol. 2021;14(3):E53–E57.  by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE Therapeutics Inc., in Bridgewater, New Jersey.  FUNDING: This study was sponsored by Foamix Pharmaceuticals Ltd., a wholly owned subsidiary of VYNE Therapeutics Inc. DISCLOSURES: Dr.

CONTINUE READING »

Severe Granulomatous Rosacea with Cutaneous Lupus Erythematosus

J Clin Aesthet Dermatol. 2021;14(2):22–24. by Rym Afiouni, MD; Josiane Helou, MD; Stephanie Matar, MD; and Roland Tomb, MD, PhD All authors are with the Department of Dermatology, Hôtel-Dieu de France University Hospital, Saint Joseph University in Beirut, Lebanon. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest

CONTINUE READING »

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

J Clin Aesthet Dermatol. 2020;13(11):44–49 by Linda Stein Gold, MD; James Q. Del Rosso, DO; Leon Kircik, MD; Neal D. Bhatia, MD; Deirdre Hooper, MD; Walter Nahm, MD, PhD; and Iain Stuart, PhD Dr. Stein Gold is with the Henry Ford Health System in Detroit, Michigan. Dr. Del Rosso is the Research Director at JDR

CONTINUE READING »